QIAGEN N.V.
QGEN
$42.07
-$0.99-2.30%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.66% | 0.62% | -1.90% | -2.99% | -8.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.66% | 0.62% | -1.90% | -2.99% | -8.23% |
| Cost of Revenue | 40.90% | 44.38% | 42.59% | -0.40% | -4.12% |
| Gross Profit | -20.04% | -21.47% | -24.04% | -4.27% | -10.21% |
| SG&A Expenses | -2.56% | -3.20% | -4.17% | -4.74% | -4.10% |
| Depreciation & Amortization | -9.10% | -7.31% | -2.73% | -0.51% | -0.07% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.21% | 17.14% | 16.35% | -2.25% | -2.87% |
| Operating Income | -52.43% | -56.77% | -63.26% | -5.44% | -22.78% |
| Income Before Tax | -71.81% | -72.61% | -76.36% | -0.60% | -16.15% |
| Income Tax Expenses | -57.57% | -74.80% | -67.13% | 18.43% | -0.99% |
| Earnings from Continuing Operations | -75.51% | -72.05% | -78.43% | -4.53% | -19.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.51% | -72.05% | -78.43% | -4.53% | -19.35% |
| EBIT | -52.43% | -56.77% | -63.26% | -5.44% | -22.78% |
| EBITDA | -37.07% | -39.09% | -43.96% | -3.94% | -17.48% |
| EPS Basic | -76.00% | -72.55% | -78.83% | -5.02% | -19.64% |
| Normalized Basic EPS | -49.92% | -52.06% | -58.41% | -2.79% | -16.16% |
| EPS Diluted | -76.35% | -72.95% | -79.25% | -4.99% | -19.38% |
| Normalized Diluted EPS | -50.02% | -52.18% | -58.59% | -2.74% | -16.05% |
| Average Basic Shares Outstanding | 0.54% | 0.53% | 0.49% | 0.47% | 0.24% |
| Average Diluted Shares Outstanding | 0.23% | 0.22% | 0.24% | 0.49% | 0.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |